Drug intelligence / Profile preview

Synovex Choice

Development stage
Unknown
Lead developer
Zoetis
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
Administration
Subcutaneous Implant
01

Overview

Synovex Choice is a combination growth-promoting implant for use in beef cattle, specifically steers and heifers, to increase the rate of weight gain and improve feed efficiency. Each implant contains 100 mg trenbolone acetate (a synthetic anabolic steroid) and 14 mg estradiol benzoate (an estrogenic compound). The product is administered as a subcutaneous ear implant and is approved for use in growing beef steers and heifers on pasture, in dry lot, or fed in confinement for slaughter. The mechanism of action involves the combined anabolic effects of trenbolone acetate (androgen receptor agonist) promoting muscle growth, and estradiol benzoate (estrogen receptor agonist) enhancing protein synthesis. Developed by Zoetis, it is FDA-approved under NADA #141-043[4][6][7]. Recent label expansions allow its use for increased weight gain in cattle on pasture as well as those fed in confinement[9].

Brand names
Synovex Choice
02

Targets

AR (Adrenergic receptors)ER (Estrogen receptor)

Beyond the preview

Go deeper on Synovex Choice.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synovex Choice.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call